We appreciate the positive comments of Drs Ditmanson and Apgar. In response to their specific questions, the patients were not followed-up in a systematic fashion after discharge, although many of these patients were seen in the outpatient clinic. On careful review, none of the patients were readmitted to the hospital with relapse or recurrence of pneumonia within 30 days.
In response to the second question, the patients were given a prescription for oral antibiotics for the follow-up therapy: doxycycline for the doxycycline group and other appropriate regimens for control group patients, The cost difference between the doxycycline and the control group for the follow-up oral therapy was not calculated. We believe this was probably a significant difference although less dramatic than the cost difference for the inpatient therapy.
Ailani RK, Agastya G, Ailani R, Mukunda BN, Shekar R. Treatment for Community Acquired Pneumonia: More Support for Doxycycline. Arch Intern Med. 1999;159(15):1811-1817. doi: